Overview
Availability
- Honorary Professor Josephine Forbes is:
- Available for supervision
Qualifications
- Bachelor, University of Melbourne
- Doctor of Philosophy, University of Melbourne
Works
Search Professor Josephine Forbes’s works on UQ eSpace
2017
Journal Article
Vascular complications in diabetes: old messages, new thoughts
Forbes, Josephine M. and Fotheringham, Amelia K. (2017). Vascular complications in diabetes: old messages, new thoughts. Diabetologia, 60 (11), 2129-2138. doi: 10.1007/s00125-017-4360-x
2017
Journal Article
Serum 25-hydroxyvitamin D concentrations are associated with nuclear factor kappa-B activity but not with inflammatory markers in healthy normoglycemic adults
Mousa, Aya, de Courten, Maximilian P. J., Forbes, Josephine and de Courten, Barbora (2017). Serum 25-hydroxyvitamin D concentrations are associated with nuclear factor kappa-B activity but not with inflammatory markers in healthy normoglycemic adults. Journal of Steroid Biochemistry and Molecular Biology, 177, 216-222. doi: 10.1016/j.jsbmb.2017.07.013
2017
Journal Article
Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial
Baye, Estifanos, de Courten, Maximilian P. J., Walker, Karen, Ranasinha, Sanjeeva, Earnest, Arul, Forbes, Josephine M. and de Courten, Barbora (2017). Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial. Scientific Reports, 7 (1) 4123, 4123. doi: 10.1038/s41598-017-04214-6
2017
Journal Article
Disparity in the micronutrient content of diets high or low in advanced glycation end products (AGEs) does not explain changes in insulin sensitivity
Pearce, Karma, Hatzinikolas, Alicia, Moran, Lisa, de Courten, Maximilian P. J., Forbes, Josephine, Scheijen, Jean L. J. M., Schalkwijk, Casper G., Walker, Karen and de Courten, Barbora (2017). Disparity in the micronutrient content of diets high or low in advanced glycation end products (AGEs) does not explain changes in insulin sensitivity. International Journal of Food Sciences and Nutrition, 68 (8), 1-6. doi: 10.1080/09637486.2017.1319468
2017
Journal Article
A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes
Salonen, K. M., Ryhanen, S. J., Forbes, J. M., Harkonen, T., Ilonen, J., Simell, O., Veijola, R., Groop, P. -H. and Knip, M. (2017). A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes. Diabetes/Metabolism Research and Reviews, 33 (4) e2872, e2872. doi: 10.1002/dmrr.2872
2017
Conference Publication
Mitochondrial dysfunction defines a population of young people with type 1 diabetes at risk of kidney disease
Forbes, J. M., Flemming, N. B., Mccarthy, D. A., Boot, K., De Silva, N., Gallo, L. A., Nisbett, J., Morton, A., Teasdale, S., Thorburn, D. R., Russell, A., Isbel, N., Johnson, D., Morahan, G., Jones, T., Couper, J., Donaghue, K., Hodson, M. P. and O'Moore-Sullivan, T. (2017). Mitochondrial dysfunction defines a population of young people with type 1 diabetes at risk of kidney disease. 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD), Lisbon, Portugal, 11-15 September 2017. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia.
2017
Conference Publication
Mitochondrial dysfunction defines a population of young people with type 1 diabetes at risk of kidney disease
Forbes, J. M., Flemming, N., McCarthy, D., Boot, K., D'Silva, N., Gallo, L., Thorburn, D. R., Russell, A., Johnson, D., Morahan, G., Jones, T., Couper, J., Donaghue, K., Hodson, M. and O'Moore-Sullivan, T. (2017). Mitochondrial dysfunction defines a population of young people with type 1 diabetes at risk of kidney disease. 53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Lisbon Portugal, 11-15 September 2017. New York NY United States: Springer.
2016
Journal Article
Receptor for advanced glycation end products (RAGE) in type 1 diabetes pathogenesis
Leung, Sherman S., Forbes, Josephine M. and Borg, Danielle J. (2016). Receptor for advanced glycation end products (RAGE) in type 1 diabetes pathogenesis. Current Diabetes Reports, 16 (10) 100, 100. doi: 10.1007/s11892-016-0782-y
2016
Journal Article
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
Leung, Christopher, Herath, Chandana B., Jia, Zhiyuan, Andrikopoulos, Sof, Brown, Bronwyn E., Davies, Michael J., Rivera, Leni R., Furness, John B., Forbes, Josephine M. and Angus, Peter W. (2016). Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease. World Journal of Gastroenterology, 22 (35), 8026-8040. doi: 10.3748/wjg.v22.i35.8026
2016
Conference Publication
Understanding Novel Genetic Factors Underlying Circulating Cystatin C and Kidney Function
Fotheringham, A., Balmer, L., Morahan, G. and Forbes, J. (2016). Understanding Novel Genetic Factors Underlying Circulating Cystatin C and Kidney Function. HOBOKEN: WILEY-BLACKWELL.
2016
Journal Article
Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?
Zhuang, Aowen and Forbes, Josephine M. (2016). Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?. Glycoconjugate Journal, 33 (4), 645-652. doi: 10.1007/s10719-016-9693-z
2016
Journal Article
Targeting advanced glycation with pharmaceutical agents: where are we now?
Borg, Danielle J. and Forbes, Josephine M. (2016). Targeting advanced glycation with pharmaceutical agents: where are we now?. Glycoconjugate Journal, 33 (4), 653-670. doi: 10.1007/s10719-016-9691-1
2016
Journal Article
Mitochondria-power players in kidney function?
Forbes, Josephine M. (2016). Mitochondria-power players in kidney function?. Trends in Endocrinology and Metabolism, 27 (7), 441-442. doi: 10.1016/j.tem.2016.05.002
2016
Journal Article
Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial
de Courten, Barbora, de Courten, Maximilian P. J., Soldatos, Georgia, Dougherty, Sonia L., Straznicky, Nora, Schlaich, Markus, Sourris, Karly C., Chand, Vibhasha, Scheijen, Jean L. J. M., Kingwell, Bronwyn A., Cooper, Mark E., Schalkwijk, Casper G., Walker, Karen Z. and Forbes, Josephine M. (2016). Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial. American Journal of Clinical Nutrition, 103 (6), 1426-1433. doi: 10.3945/ajcn.115.125427
2016
Conference Publication
Reduced Insulin Sensitivity Is Associated with Increased Glomerular Filtration Rate in Healthy Nondiabetic Individuals, Independent of Body Mass Index, Adiposity, and Blood Pressure
Naderpoor, Negar, Lyons, Jasmine G., Soldatos, Georgia, Mousa, Aya, Forbes, Josephine M. and De Courten, Barbora (2016). Reduced Insulin Sensitivity Is Associated with Increased Glomerular Filtration Rate in Healthy Nondiabetic Individuals, Independent of Body Mass Index, Adiposity, and Blood Pressure. 76th Scientific Sessions of the American-Diabetes-Association, New Orleans La, Jun 10-14, 2016. ALEXANDRIA: AMER DIABETES ASSOC.
2016
Journal Article
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
Gallo, Linda A., Ward, Micheal S., Fotheringham, Amelia K., Zhuang, Aowen, Borg, Danielle J., Flemming, Nicole B., Harvie, Ben M., Kinneally, Toni L., Yeh, Shang-Ming, McCarthy, Domenica A., Koepsell, Hermann, Vallon, Volker, Pollock, Carol, Panchapakesan, Usha and Forbes, Josephine M. (2016). Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice. Scientific Reports, 6 (1) 26428, 28124. doi: 10.1038/srep26428
2016
Journal Article
Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejection
Coleman, Miranda A., Jessup, Claire F., Bridge, Jennifer A., Overgaard, Nana H., Penko, Daniella, Walters, Stacey, Borg, Danielle J., Galea, Ryan, Forbes, Josephine M., Thomas, Ranjeny, Coates, Patrick T. C., Grey, Shane T., Wells, James W. and Steptoe, Raymond J. (2016). Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejection. Diabetes, 65 (5), 1328-1340. doi: 10.2337/db15-1418
2016
Conference Publication
The SGLT2 Inhibitor, Empagliflozin, Attenuates Some Markers of Renal Fibrosis without Improving Albuminuria in Diabetic <i>Db</i>/<i>Db</i> Mice
Gallo, Linda A., Ward, Micheal S., Fotheringham, Amelia K., Zhuang, Aowen, Koepsell, Hermann, Vallon', Volker, Pollock, Carol, Panchapakesan, Usha and Forbes, Josephine M. (2016). The SGLT2 Inhibitor, Empagliflozin, Attenuates Some Markers of Renal Fibrosis without Improving Albuminuria in Diabetic Db/Db Mice. Experimental Biology Meeting, San Diego Ca, Apr 02-06, 2016. BETHESDA: FEDERATION AMER SOC EXP BIOL.
2016
Journal Article
Deficiency in apoptosis-inducing factor recapitulates chronic kidney disease via aberrant mitochondrial homeostasis
Coughlan, Melinda T., Higgins, Gavin C., Tuong-Vi Nguyen, Penfold, Sally A., Thallas-Bonke, Vicki, Tan, Sih Mm, Ramm, Georg, Van Bergen, Nicole J., Henstridge, Darren C., Sourris, Karly C., Harcourt, Brooke E., Trounce, Ian A., Robb, Portia M., Laskowski, Adrienne, McGee, Sean L., Genders, Amanda J., Walder, Ken, Drew, Brian G., Gregorevic, Paul, Qian, Hongwei, Thomas, Merlin C., Jerums, George, Macisaac, Richard J., Skene, Alison, Ekinci, Elif I., Wijeyeratne, Xiaonan W., Gallo, Linda A., Heiman-Edelstein, Michal, Ryan, Michael T. ... Forbes, Josephine M. (2016). Deficiency in apoptosis-inducing factor recapitulates chronic kidney disease via aberrant mitochondrial homeostasis. Diabetes, 65 (4), 1085-1098. doi: 10.2337/db15-0864
2016
Conference Publication
The SGLT2 Inhibitor, Empagliflozin, Attenuates Some Markers of Renal Fibrosis without Improving Albuminuria in Diabetic Db/Db Mice
Gallo, Linda A., Ward, Micheal S., Fotheringham, Amelia K., Zhuang, Aowen, Koepsell, Hermann, Vallon, Volker, Pollock, Carol, Panchapakesan, Usha and Forbes, Josephine M. (2016). The SGLT2 Inhibitor, Empagliflozin, Attenuates Some Markers of Renal Fibrosis without Improving Albuminuria in Diabetic Db/Db Mice. Experimental Biology 2016 Meeting, San Diego, CA United States, 1-5 April 2016. Hoboken, NJ United States: John Wiley & Sons. doi: 10.1096/fasebj.30.1_supplement.740.18
Funding
Current funding
Supervision
Availability
- Honorary Professor Josephine Forbes is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
New insights into molecular pathways involved in the development of diabetic kidney disease: Towards earlier disease detection and identification of novel therapeutic targets
Principal Advisor
Other advisors: Associate Professor Ross Francis
-
Doctor Philosophy
Early mitochondrial dysfunction in diabetic kidney
Principal Advisor
Other advisors: Dr Amelia Fotheringham, Dr Irina Buckle
-
Doctor Philosophy
sRAGE as a preventative therapy for T1D and potential biomarker of pregnancy complications
Principal Advisor
Other advisors: Dr Amelia Fotheringham, Professor Emma Hamilton-Williams, Dr Irina Buckle, Dr Sherman Leung
-
Doctor Philosophy
The receptor for advanced glycation end products and its role in Type 1 diabetes development
Principal Advisor
Other advisors: Dr Amelia Fotheringham, Professor Emma Hamilton-Williams, Dr Irina Buckle, Dr Sherman Leung
-
Doctor Philosophy
Unravelling the role of abnormal glycogen accumulation in diabetic kidney disease
Associate Advisor
Other advisors: Dr Mitchell Sullivan
-
Doctor Philosophy
The Characterisation of Immune Cells in Response To RAGE Antagonism Therapy in Mouse Models of Type 1 Diabetes
Associate Advisor
Other advisors: Professor Benjamin Schulz, Dr Amelia Fotheringham, Dr Irina Buckle
-
Doctor Philosophy
Unravelling the role of abnormal glycogen accumulation in diabetic kidney disease
Associate Advisor
Other advisors: Dr Mitchell Sullivan
Completed supervision
-
2021
Doctor Philosophy
Mitochondrial dysfunction as a pathological mediator in diabetic kidney disease
Principal Advisor
-
2020
Doctor Philosophy
Novel dietary factors in diabetic and non-diabetic kidney disease
Principal Advisor
Other advisors: Dr Danielle Borg
-
2020
Doctor Philosophy
The role of receptor for advanced glycation end products (RAGE) in the development of type 1 diabetes
Principal Advisor
Other advisors: Honorary Professor Kristen Radford, Dr Danielle Borg
-
2018
Doctor Philosophy
Novel role of AGE-R1/OST48 in the metabolome and proteome promoting ER stress in the kidney and liver
Principal Advisor
Other advisors: Professor Benjamin Schulz
-
2023
Doctor Philosophy
Kidneys on fire: The role of inflammasome signalling in human chronic kidney disease
Associate Advisor
Other advisors: Dr Andrew Kassianos
-
2019
Doctor Philosophy
Nutritional management of hyperglycaemia in intensive care medicine
Associate Advisor
Other advisors: Professor David Sturgess
Media
Enquiries
For media enquiries about Honorary Professor Josephine Forbes's areas of expertise, story ideas and help finding experts, contact our Media team: